Benzinga.com

With FDA Approval For Its LIBERTY Endovascular Robotic System, Microbot Medical Is Raring To Go

Harel Gadot, CEO of Microbot Medical Inc. (NASDAQ:MBOT), was recently a guest on Benzinga's All Access. Microbot Medical makes the LIBERTY® Endovascular Robotic System, a single-use, fully disposable ...

Microbot Medical Highlights LIBERTY Robotics at ISET Symposium

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Seeking Alpha

Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, presented for the first time the data from its ...
Nasdaq

Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics

Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...

Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System

Microbot Medical Inc. MBOT shares are up on Tuesday following the announcement that Tampa General Hospital has become the first health system in Florida to adopt the company’s LIBERTY Endovascular ...

Microbot Showcases LIBERTY Robot at Surgical Innovation Summit

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.
Hosted on MSN

Microbot Medical secures grant for endovascular robotic system

Microbot Medical has secured a non-dilutive NIS2.15m (around $630,000) grant from the Israel Innovation Authority (IIA) to bolster its manufacturing capabilities, as well as progress towards the ...
Seeking Alpha

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced its participation in the inaugural ...
Business Insider

Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System

HINGHAM, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY ® Endovascular Robotic System, announces that its Chief ...
Mena FN

Microbot Medical®'S LIBERTY® Endovascular Robotic System Continues To Expand Market Visibility Being Featured At An Industry Leading Innovation Conference

(MENAFN- GlobeNewsWire - Nasdaq) Global Robotic Leaders Convene to Discuss & Highlight Surgical Advancements of the Next Decade with a Special Focus on the Endovascular Space HINGHAM, Mass., Feb. 19, ...
Nasdaq

Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System

Microbot Medical Inc. MBOT recently received FDA 510(k) clearance for its LIBERTY Endovascular Robotic System, marking a major regulatory milestone for the company. The LIBERTY system is designed to ...